Your session is about to expire
← Back to Search
Healthy participants for Injection Site Reaction
Study Summary
This trial will test whether the SWI Device is safe and effective in healthy volunteers.
- Injection Site Reaction
- Injection Site
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Is this research endeavor actively enrolling participants?
"Affirmative. Clinicaltrials.gov shows that this medical study, which was initially listed on August 23rd 2021, is actively recruiting individuals for participation. The trial necessitates 20 patients to be enrolled from one location."
How many individuals have volunteered to participate in this experiment?
"Affirmative. According to clinicaltrials.gov, this research project began recruiting on August 23rd 2021 and has since been updated on January 20th 2022. The investigators are looking for a cohort of 20 patients from one medical institution."
Which patient profiles are eligible to participate in this medical experiment?
"Eligible applicants for this clinical trial must have experienced infusion site reactions and be between 18-40 years old. Currently, there are 20 spots available."
Can septuagenarians participate in this experiment?
"The inclusion criteria for this research program states that only individuals aged between 18 and 40 are eligible to participate. Nevertheless, there are still other trials available for those younger than 18 or older than 65 with 8 programs in total."
Share this study with friends
Copy Link
Messenger